Tysabri Cost Data Shows Up To $23,274 Benefit Over Other MS Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Biogen Idec/Elan report data showing a treatment cost benefit with Tysabri based on multiple sclerosis relapses avoided.